This content is machine translated Rheumatoid arthritis What extended benefits do currently used medications provide? Rheumatoid arthritis (RA) is a chronic disease that causes swelling and, consequently, restricted movement and joint pain. It is twice as common in women as in men, and the incidence…
View Post 3 min This content is machine translated Sexually transmitted infections Importance of venereology continues to grow First, the good news: Sexually transmitted infections (STIs) are generally preventable and usually treatable. For years, however, everyday clinical practice has shown a different picture. Recently, it was strongly suggested…
View Post 4 min This content is machine translated Juvenile idiopathic arthritis Aggressive combination therapy leads to faster disease inactivity Juvenile idiopathic arthritis (JIA), also called juvenile rheumatoid arthritis, is a collective term for several forms of arthritis, all of which involve chronic long-term joint inflammation. This inflammation begins in…
View Post 7 min This content is machine translated Non-gonorrheal urethritis Pathogen spectrum, clarification and therapy Traditionally, infectious urethritis is divided into two groups: Gonococcal urethritis (GU) and so-called non-gonorrheic urethritis (NGU). This classification arose historically to distinguish NGU-a group of infections of similar symptomatology with,…
View Post 5 min This content is machine translated Apremilast PDE4 inhibition in the treatment of inflammatory diseases. The PDE-4 inhibitor apremilast was discussed as a potential option in the treatment of psoriatic arthritis at this year’s ACR Congress in San Diego. Promising results show good efficacy both…
View Post 3 min This content is machine translated Psoriatic Arthritis Therapeutic options and results There are increasing signs of success in the treatment not only of rheumatoid arthritis (RA), but also of psoriatic arthritis (PsA). At the ACR Congress in San Diego, researchers were…
View Post 6 min This content is machine translated Stroke prevention in VHF Real-life data with dabigatran convincing For the first time, real-life data are available for one of the new oral anticoagulants. These were presented in Zurich on October 2, 2013. They demonstrate a compelling safety and…
View Post 2 min This content is machine translated On the farewell of Prof. Philippe Lyrer Partir, c’est mourir un peu Dear Philippe. Ten years ago, in the fall of 2003, we published the first issue of InFo NEUROLOGIE & PSYCHIATRIE together – you as the editor of Neurology, me as…
View Post 2 min This content is machine translated Thrust-remitting MS An update on basic oral therapy Several encouraging advances have been made in the treatment of relapsing-remitting multiple sclerosis (MS) in recent years. Thus, the first orally administered substance – fingolimod – now also has a…
View Post 4 min This content is machine translated 86th Congress of the German Society of Neurology Highlights from the DGN Congress 2013 This year’s meeting of the German Society of Neurology took place in Dresden from September 18-21, 2013. We have selected four exciting studies that were highlighted at this congress.
View Post 3 min This content is machine translated Approval Teriflunomide (Aubagio®) Significantly lower risk of disability progression The more a patient with MS is limited in different areas of life by his increasing disability, the worse his health status becomes. In Switzerland, an oral MS treatment, teriflunomide,…
